Zhao Wei-Wei, Shi Qing-Hong, Sun Yan
Department of Biochemical Engineering and Key Laboratory of Systems Bioengineering of the Ministry of Education, School of Chemical Engineering and Technology, Tianjin University, Tianjin 300072, China.
Department of Biochemical Engineering and Key Laboratory of Systems Bioengineering of the Ministry of Education, School of Chemical Engineering and Technology, Tianjin University, Tianjin 300072, China; Collaborative Innovation Center of Chemical Science and Engineering (Tianjin), Tianjin 300072, China.
J Chromatogr A. 2014 Aug 15;1355:107-14. doi: 10.1016/j.chroma.2014.05.083. Epub 2014 Jun 6.
This work reports the development of an octapeptide-based affinity adsorbent for the purification of human IgG (hIgG) and monoclonal antibody (mAb). The octapeptide was FYWHCLDE selected earlier by the biomimetic design of affinity peptide ligands for hIgG. The ligand was coupled to Sepharose gel at four densities from 10.4 to 31.0μmol/mL, and the effect of peptide density on the adsorption of hIgG and bovine serum albumin (BSA) was first investigated. The binding capacity of hIgG increased from 104.2 to 176.4mg/mL within the ligand density range, and the binding affinity (dissociation constant) kept at 2.4-3.7μM. Batch adsorption revealed that the selectivity of FYWHCLDE-Sepharose for IgG was 30-40 times over BSA. The effective pore diffusivity of IgG decreased somewhat with increasing ligand density, but the dynamic binding capacity at 10% breakthrough, measured by using 10-fold diluted human serum as feedstock, doubled with increasing ligand density from 10.4 to 31.0μmol/mL due to the remarkable increase of static binding capacity. By using the affinity column with a ligand density of 23.9μmol/mL, hIgG and humanized mAb purifications from human serum and cell culture supernatant, respectively, were achieved at high purities and recovery yields. Finally, the robustness of the peptide gel was demonstrated by recycled use of the affinity column in 20 breakthrough cycles.
本研究报道了一种基于八肽的亲和吸附剂的开发,用于纯化人免疫球蛋白G(hIgG)和单克隆抗体(mAb)。该八肽FYWHCLDE是先前通过对hIgG亲和肽配体的仿生设计筛选得到的。将该配体以10.4至31.0μmol/mL的四种密度偶联到琼脂糖凝胶上,首次研究了肽密度对hIgG和牛血清白蛋白(BSA)吸附的影响。在配体密度范围内,hIgG的结合容量从104.2mg/mL增加到176.4mg/mL,结合亲和力(解离常数)保持在2.4 - 3.7μM。分批吸附表明,FYWHCLDE - 琼脂糖对IgG的选择性是对BSA的30 - 40倍。IgG的有效孔扩散率随配体密度增加略有下降,但由于静态结合容量显著增加,以10倍稀释的人血清为原料,在10%穿透率下测得的动态结合容量随配体密度从10.4μmol/mL增加到31.0μmol/mL而翻倍。使用配体密度为23.9μmol/mL的亲和柱,分别从人血清和细胞培养上清液中实现了高纯度和高回收率的hIgG和人源化mAb的纯化。最后,通过亲和柱在20次穿透循环中的循环使用证明了肽凝胶的稳定性。